Petroula Proitsi

发表

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

Magda Tsolaki, Giovanni B. Frisoni, Min Kim, 2019, Alzheimer's & dementia.

Smell identification function as a severity and progression marker in Alzheimer's disease

Simon Lovestone, Megan Pritchard, Latha Velayudhan, 2013, International Psychogeriatrics.

Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2011, Journal of Alzheimer's disease : JAD.

Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2010, Journal of Alzheimer's disease : JAD.

Association of a Locus in the CAMTA 1 GeneWith Survival in PatientsWith Sporadic Amyotrophic Lateral Sclerosis

Adriano Chiò, Philip Van Damme, Aleksey Shatunov, 2016 .

Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

Seth Love, Brian Lawlor, Martin Rossor, 2010, PloS one.

Positional Pathway Screen of wnt Signaling Genes in Schizophrenia: Association with DKK4

Marta Di Forti, Simon Lovestone, Pak Sham, 2008, Biological Psychiatry.

Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study.

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2013, Journal of Alzheimer's disease : JAD.

Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis

Magda Tsolaki, Bruno Vellas, Hilkka Soininen, 2014, PLoS medicine.

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

Magda Tsolaki, Bruno Vellas, Andrew Simmons, 2014, Alzheimer's & Dementia.

Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS)

Simon Lovestone, Olivia Belbin, Kevin Morgan, 2012, Neurobiology of Aging.

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.

Susan M Resnick, Magda Tsolaki, Luigi Ferrucci, 2010, Archives of general psychiatry.

APOE ε2 Allele Is Associated with Larger Regional Cortical Thicknesses and Volumes

Alan C. Evans, Magda Tsolaki, Bruno Vellas, 2010, Dementia and Geriatric Cognitive Disorders.

Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study

Magda Tsolaki, Bruno Vellas, Eric Westman, 2013, Alzheimer's & Dementia.

Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.

Sandra D'Alfonso, Adriano Chiò, Aleksey Shatunov, 2016, JAMA neurology.

A blood gene expression marker of early Alzheimer's disease.

Magda Tsolaki, Richard Dobson, Bruno Vellas, 2013, Journal of Alzheimer's disease : JAD.